SYNERON MEDICAL LTD - ORD SHS (ELOS)

CUSIP: M87245102

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / ORD SHS
Total 13F shares
21,432,789
Share change
-2,893,548
Total reported value
$234,699,868
Price per share
$10.95
Number of holders
78
Value change
-$27,283,772
Number of buys
45
Number of sells
63

Quarterly Holders Quick Answers

What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q2 2017

As of 30 Jun 2017, SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,432,789 shares. The largest 10 holders included BRANDES INVESTMENT PARTNERS, LP, Camber Capital Management LLC, GARDNER LEWIS ASSET MANAGEMENT L P, CNH PARTNERS LLC, K2 PRINCIPAL FUND, L.P., Vivaldi Asset Management, LLC, DALTON GREINER HARTMAN MAHER & CO, Migdal Insurance & Financial Holdings Ltd., RENAISSANCE TECHNOLOGIES LLC, and SG Americas Securities, LLC. This page lists 78 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.